Pictet Asset Management (Switzerland)’s ChemoCentryx, Inc. CCXI Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,900	Closed	-$201K	–	2033
2022 Q3	$201K	Sell	3,900 -2,368,745	-100%	-$97.9M	﹤0.01%	1416
2022 Q2	$58.8M	Buy	2,372,645 +532,478	+29%	+$11.7M	0.08%	258
2022 Q1	$46.1M	Buy	1,840,167 +234,758	+15%	+$6.6M	0.05%	328
2021 Q4	$58.5M	Buy	+1,605,409	New	+$56.4M	0.06%	318

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s CCXI Position: Q4 2022 in Review

Pictet Asset Management (Switzerland) sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 3,900 shares — an estimated $201K sold.

Pictet Asset Management (Switzerland) first reported a position in CCXI in Q4 2021 and held it in 4 quarters. The position peaked at $58.8M in Q2 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Pictet Asset Management (Switzerland) reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Pictet Asset Management (Switzerland) sold 3,900 ChemoCentryx, Inc. shares in Q4 2022, an estimated $201K.
Pictet Asset Management (Switzerland) first reported a position in ChemoCentryx, Inc. in Q4 2021 and held it in 4 quarters.
Pictet Asset Management (Switzerland)'s ChemoCentryx, Inc. position peaked at $58.8M in Q2 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q4 2022, filed 13 Feb 2023.